Union Minister J P Nadda chairs high level review meeting on control of vector borne diseases

2017-07-07 03:17:09

During the meeting, Minister Nadda asked the States for mounting aggressive IEC campaigns to enhance awareness on prevention and control of vectors in their surrounding areas and neighborhoods. By Team ABLEUnion Minister for Health and Family Welfare J P Nadda, on July 4, 2017, held a high-level meeting to review the preparedness of the Ministry for prevention and control of vector borne dise

Read more

Sun Pharma, Samsung BioLogics join hands to tie-up for Tildrakizumab

2017-07-07 03:11:10

By Team ABLESun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational therapeutic for the treatment of moderate to severe plaque psoriasis.Sun Pharma and South Korea-based Samsung BioLogics have announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma’s wholly-owned subsidiary and Samsung BioLog

Read more

India to grant marketing authorization for BIOCAD’s rituximab biosimilar

2017-07-07 03:09:21

On June 20, 2017, the Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab biosimilar made in Russia, for approval in India.By Team ABLERussia’s BIOCAD has announced that on June 20, 2017 the company has received a recommendation from the Central Drugs Standard Control Organization (CDSCO) to market its Acellbia, a rituximab biosimilar, for the Indian

Read more

Union Minister J P Nadda chairs high level review meeting on control of vector borne diseases

2017-07-07 03:06:45

During the meeting, Minister Nadda asked the States for mounting aggressive IEC campaigns to enhance awareness on prevention and control of vectors in their surrounding areas and neighborhoods. \n\nBy Team ABLE\n\nUnion Minister for Health and Family Welfare J P Nadda, on July 4, 2017, held a high-level meeting to review the preparedness of the Ministry for prevention and control of vector borne d

Read more

Zydus Cadila signs agreement to license Israel\'s Phibro Animal Health’s poultry vaccine technologies

2017-07-06 08:43:22

Zydus Cadila will license Phibro’s poultry vaccine technologies, which will be manufactured in India.By Team ABLEIsrael’s Phibro Animal Health Corporation and Zydus Cadila have announced their intention to enter into a long-term arrangement to license Phibro’s poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Zydus Cadila. Jack Bendheim, Chairma

Read more

Pharmatest signs deal to exploit Taconic’s humanized mouse models for bone cancer research

2017-07-06 08:42:00

Researchers are hopeful that this new model will address incurable and painful diseaseBy Team ABLEUS-based Taconic Biosciences has signed a collaborative agreement with Pharmatest Services to leverage the company’s oncology and skeletal disease preclinical efficacy services using Taconic’s humanized mouse models.Taconic Biosciences is a fully-licensed, global leader in genetically engineered r

Read more

Dr Tedros Adhanom Ghebreyesus assumes office as WHO Director-General

2017-07-03 20:34:33

Dr Tedros Adhanom Ghebreyesus assumed office as Director-General of the World Health Organization, succeeding Dr Margaret ChanBy Team ABLEOn July 1, 2017, Dr Tedros Adhanom Ghebreyesus assumed office as Director-General of the World Health Organization, succeeding Dr Margaret Chan, who has held office since January 1, 2007.The Director-General is WHO\'s chief technical and administrative officer a

Read more

GSK to exploit Artificial Intelligence for drug discovery; strikes deal with Exscientia

2017-07-03 20:33:18

Pre-clinical collaboration focused on up to 10 targets nominated by GSKBy Team ABLEExscientia, the company that provides Artificial Intelligence (AI)-driven drug discovery solutions, has entered into a strategic drug discovery collaboration with pharma major GlaxoSmithKline (GSK). During this collaboration, Exscientia will apply its AI enabled platform and combine this with the expertise of GSK, i

Read more

New clues found to common respiratory virus; discovery provides potential target for vaccines, treatments

2017-07-03 20:31:30

Researchers at Washington University School of Medicine in St. Louis, have found clues to how RSV causes disease.By Team ABLEBy age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the elderly, can face serious complications, including pneumonia and -- in some cases

Read more

Revita Life Sciences decides to continue study on brain dead subjects

2017-07-03 20:28:40

Revita Life Sciences has announced that it is continuing to advance its multi-modality clinical intervention in the state of brain death in humans.By Team ABLERevita Life Sciences, a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance its multi-modality clinical intervention in the state of brain death in humans.“We

Read more